慢性阻塞性肺疾病的发病率(慢性阻塞性肺病)和囊性纤维化在整个地区呈上升趋势。根据世界卫生组织 (WHO) 的说法,慢性阻塞性肺病加重是慢性阻塞性肺病历史上的关键事件。此外,与慢性阻塞性肺病相关的残疾和死亡率推动了对振荡呼气正压 (OPEP) 设备的需求。哮喘在所有年龄、性别和种族的人群中变得越来越常见。根据新西兰奥克兰发布的 2018 年全球哮喘报告,按照残疾调整生命年评估,哮喘是第 16 大残疾原因和第 28 大疾病负担来源。哮喘在高收入国家很常见,而大多数与哮喘相关的死亡发生在低收入和中等收入国家。因此,慢性阻塞性肺病和哮喘患病率的上升推动了对 OPEP 设备等粘液清除设备的需求,从而促进了振荡呼气正压 (OPEP) 设备市场的增长。
  ;
凭借新功能和先进技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能推动欧洲振荡正压 (OPEP) 设备市场在预测期内实现显着的复合年增长率。
欧洲振荡正压呼气 (OPEP) 设备市场细分
< /p>
欧洲振荡呼气正压 (OPEP) 设备市场根据产品、适应症、分销渠道和国家/地区进行细分。根据产品,市场分为吸嘴 PEP 设备、面罩 PEP 设备和瓶子 PEP 设备。 2021年,吸嘴PEP设备细分市场占据最大市场份额;并且在预测期内可能会出现最高的复合年增长率。根据适应症,市场分为慢性阻塞性肺病(COPD)、哮喘、支气管炎、支气管扩张、囊性纤维化等。 2021年,慢性阻塞性肺疾病(COPD)细分市场占据最大市场份额;然而,在预测期内,哮喘细分市场的复合年增长率可能最高。根据分销渠道,市场分为医院药房、零售药房和网上药房。 2021年,医院药房领域占据最大市场份额;然而,预计零售药房领域在预测期内将实现市场上最高的复合年增长率。此外,根据国家/地区,市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。 2021 年,德国占据最大的市场份额,预计法国在预测期内的复合年增长率最高。
Allergan Plc。 ;帕里有限公司;史密斯医疗;空气物理;水星医疗; CEGLA 医疗技术有限公司两合公司;和 Medica Holdings, LLC 是欧洲振荡正压 (OPEP) 设备市场上的一些领先公司。
Strategic insights for Europe Oscillating Positive Expiratory Pressure (OPEP) Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 54.50 Million |
Market Size by 2028 | US$ 39.00 Million |
Global CAGR (2021 - 2028) | 4.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Oscillating Positive Expiratory Pressure (OPEP) Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market is valued at US$ 54.50 Million in 2021, it is projected to reach US$ 39.00 Million by 2028.
As per our report Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market, the market size is valued at US$ 54.50 Million in 2021, projecting it to reach US$ 39.00 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.
The Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market report:
The Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market value chain can benefit from the information contained in a comprehensive market report.